Efficacy of ciclesonide on small airways in patients with stable asthma (18 to 60 y) (BY9010/M1-131)
Study identifier:BY9010/M1-131
ClinicalTrials.gov identifier:NCT00163345
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Evaluation of parameters of the small airways and their changes under treatment with ciclesonide (320 mcg once daily) versus placebo in patients with asthma
Medical condition
asthma
Phase
Phase 3
Healthy volunteers
No
Study drug
Ciclesonide
Sex
All
Actual Enrollment
20
Study type
Interventional
Age
18 Years - 60 Years
Date
Study Start Date: 01 Sept 2003
Primary Completion Date: 01 May 2006
Study Completion Date: 01 May 2006
Study design
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment
Verification:
Verified 01 Dec 2016 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
AstraZeneca AstraZeneca
AstraZeneca
